Nyxoah is a medical device company based in Belgium that develops implantable neurostimulation treatments for obstructive sleep apnea. Its main product, the Genio system, stimulates the hypoglossal nerve to keep the airway open during sleep. The device is placed under the skin without leads and is powered and controlled wirelessly by an external unit worn by the patient. The company serves sleep medicine specialists and patients who cannot tolerate other apnea therapies.
Nyxoah trades under the code NYXH on the Euronext Brussels in Belgium, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #106 of 111 on the Euronext Brussels · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Belgium yet.
TrendWeak
3/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-67.4%
From 52-week high-85.4%
MomentumWeak
3/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-46.5%
6-month return-73.8%
12-month, skipping last month-75.1%
Stability (higher is calmer)Weak
5/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)85.4%
Worst drawdown, 1 year (smaller is calmer)-85.4%
LiquidityFair
58/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.30M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Belgium when fundamentals data for this market is added. All Belgium stocks.
52-wk range 0.697 – 5.140Daily closes, split-adjusted
Signals
50-day average1.278
200-day average2.244
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.094
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 0 neutral · 7 bearish
Moving averages (daily)
SMA 10
1.00
Bearish
EMA 10
0.96
Bearish
SMA 20
1.13
Bearish
EMA 20
1.08
Bearish
SMA 50
1.28
Bearish
EMA 50
1.24
Bearish
SMA 100
1.35
Bearish
EMA 100
1.52
Bearish
SMA 200
2.24
Bearish
EMA 200
2.27
Bearish
Oscillators (daily)
RSI (14)
23.06
Bullish
MACD (12, 26)
-0.13
Bearish
Momentum (12)
-42.81
Bearish
Stochastic %K (14)
5.75
Bullish
Williams %R (14)
-94.25
Bullish
CCI (20)
-186.4
Bullish
Pivot points (classic, last session)
S3
0.50
S2
0.60
S1
0.67
Pivot
0.76
R1
0.83
R2
0.93
R3
0.99
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
